Another Icon safety innovation is the high-definition motion management (HDMM) system, which monitor's the patient's head during treatment via infrared tracking of a marker on the nose. If movement exceeds a certain threshold set by the physician (1-1.5 mm at ETZ), treatment stops.
For the three frameless treatments we've done so far, we were pleased to see that the motion management system did not activate," Dr. Beute recalls. "That tells me that patient immobilization is very secure."
Ad Statistics
Times Displayed: 22687
Times Visited: 478 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Dr. Beute anticipates performing 40-60 frameless treatments in the first year with Icon, in addition to the usual 650 frame-based Gamma Knife radiosurgeries. ETZ has been using Gamma Knife technology since 2002.
Together with his colleague Dr. Patrick Hanssens, Dr. Beute will serve as co-chairman of the 18th Leksell Gamma Knife Society meeting, which convenes in Amsterdam May 15-19. The scientific program will focus on interactive presentations moderated by experts in the field of radiosurgery and other relevant medical fields. The meeting is expected to draw 500 participants from 40 countries and a record number of abstracts.
To learn more about Leksell Gamma Knife Icon, visit http://www.careforthebrain.com.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: http://www.elekta.com.
SOURCE Elekta
Back to HCB News
